| Nome |
# |
|
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group, file dd9e0c65-e8e4-1e9c-e053-3a05fe0a45ef
|
428
|
|
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration, file dd9e0c66-e48c-1e9c-e053-3a05fe0a45ef
|
173
|
|
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution, file dd9e0c6a-f649-1e9c-e053-3a05fe0a45ef
|
143
|
|
The EULAR Study Group for Registers and Observational Drug Studies: Comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers, file dd9e0c65-9a26-1e9c-e053-3a05fe0a45ef
|
141
|
|
Digital ulcers predict a worse disease course in patients with systemic sclerosis, file dd9e0c66-34a7-1e9c-e053-3a05fe0a45ef
|
120
|
|
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings, file dd9e0c6b-2d1c-1e9c-e053-3a05fe0a45ef
|
95
|
|
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment, file dd9e0c65-8eba-1e9c-e053-3a05fe0a45ef
|
71
|
|
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis, file dd9e0c64-d1de-1e9c-e053-3a05fe0a45ef
|
69
|
|
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases, file dd9e0c65-a994-1e9c-e053-3a05fe0a45ef
|
69
|
|
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study, file dd9e0c65-2d58-1e9c-e053-3a05fe0a45ef
|
65
|
|
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study, file dd9e0c6a-f351-1e9c-e053-3a05fe0a45ef
|
65
|
|
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers, file dd9e0c65-8848-1e9c-e053-3a05fe0a45ef
|
57
|
|
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus, file dd9e0c65-f1e3-1e9c-e053-3a05fe0a45ef
|
57
|
|
Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis, file dd9e0c65-3a6f-1e9c-e053-3a05fe0a45ef
|
56
|
|
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors, file dd9e0c65-6832-1e9c-e053-3a05fe0a45ef
|
50
|
|
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors, file dd9e0c66-ccad-1e9c-e053-3a05fe0a45ef
|
50
|
|
Chondrocytes treated with different shock wave devices, file dd9e0c64-d0b5-1e9c-e053-3a05fe0a45ef
|
48
|
|
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study, file dd9e0c65-9128-1e9c-e053-3a05fe0a45ef
|
48
|
|
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection, file dd9e0c6a-d95f-1e9c-e053-3a05fe0a45ef
|
48
|
|
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis, file dd9e0c66-16ae-1e9c-e053-3a05fe0a45ef
|
47
|
|
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab, file dd9e0c64-c876-1e9c-e053-3a05fe0a45ef
|
46
|
|
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study, file dd9e0c6a-e198-1e9c-e053-3a05fe0a45ef
|
46
|
|
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology, file dd9e0c66-e487-1e9c-e053-3a05fe0a45ef
|
45
|
|
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries, file dd9e0c6b-20be-1e9c-e053-3a05fe0a45ef
|
45
|
|
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease, file dd9e0c66-54ed-1e9c-e053-3a05fe0a45ef
|
44
|
|
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives, file dd9e0c66-35c0-1e9c-e053-3a05fe0a45ef
|
43
|
|
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa, file dd9e0c66-4df6-1e9c-e053-3a05fe0a45ef
|
43
|
|
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials, file dd9e0c6a-de3b-1e9c-e053-3a05fe0a45ef
|
43
|
|
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study, file dd9e0c66-35be-1e9c-e053-3a05fe0a45ef
|
42
|
|
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease, file dd9e0c66-4df4-1e9c-e053-3a05fe0a45ef
|
41
|
|
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease, file dd9e0c66-4dec-1e9c-e053-3a05fe0a45ef
|
40
|
|
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study, file dd9e0c6b-1acf-1e9c-e053-3a05fe0a45ef
|
40
|
|
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives, file dd9e0c65-5b9e-1e9c-e053-3a05fe0a45ef
|
38
|
|
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project, file dd9e0c6a-f6c8-1e9c-e053-3a05fe0a45ef
|
38
|
|
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease, file dd9e0c64-9a02-1e9c-e053-3a05fe0a45ef
|
13
|
|
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study, file dd9e0c64-a6a0-1e9c-e053-3a05fe0a45ef
|
11
|
|
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study., file dd9e0c63-b5c8-1e9c-e053-3a05fe0a45ef
|
10
|
|
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy, file dd9e0c6a-b47a-1e9c-e053-3a05fe0a45ef
|
9
|
|
null, file dd9e0c66-ae07-1e9c-e053-3a05fe0a45ef
|
7
|
|
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis, file dd9e0c6a-946b-1e9c-e053-3a05fe0a45ef
|
6
|
|
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis, file dd9e0c64-9445-1e9c-e053-3a05fe0a45ef
|
5
|
|
null, file dd9e0c66-5501-1e9c-e053-3a05fe0a45ef
|
5
|
|
null, file dd9e0c63-13be-1e9c-e053-3a05fe0a45ef
|
4
|
|
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration, file dd9e0c67-8810-1e9c-e053-3a05fe0a45ef
|
4
|
|
Complete Relief of a Severe Feet and Hand Necrotising Raynaud’s Phenomenon with Double Epidural Cervical and Dorsal Spinal Cord Stimulation, file dd9e0c67-ac26-1e9c-e053-3a05fe0a45ef
|
4
|
|
Imputing missing data of function and disease activity in rheumatoid arthritis registers: What is the best technique?, file dd9e0c69-7619-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c64-c6c8-1e9c-e053-3a05fe0a45ef
|
3
|
|
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan, file dd9e0c65-59cf-1e9c-e053-3a05fe0a45ef
|
3
|
|
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers, file dd9e0c65-6759-1e9c-e053-3a05fe0a45ef
|
3
|
|
null, file dd9e0c65-89e8-1e9c-e053-3a05fe0a45ef
|
3
|
|
Response of cartilage oligomeric matrix protein to monoclonal antibody drugs in patients with rheumatoid arthritis, file dd9e0c66-1955-1e9c-e053-3a05fe0a45ef
|
3
|
|
null, file dd9e0c66-9972-1e9c-e053-3a05fe0a45ef
|
3
|
|
null, file dd9e0c67-2eab-1e9c-e053-3a05fe0a45ef
|
3
|
|
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease, file dd9e0c67-8816-1e9c-e053-3a05fe0a45ef
|
3
|
|
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis, file dd9e0c6c-07bc-1e9c-e053-3a05fe0a45ef
|
3
|
|
Genetic and clinical features of Familial Mediterranean Fever (FMF) in a homogeneous cohort of patients from south-eastern Italy, file 82d46104-afab-4ab3-ac9a-3fc98fe368bc
|
2
|
|
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy, file dd9e0c63-11d2-1e9c-e053-3a05fe0a45ef
|
2
|
|
THE INHIBITOR OF COSTIMULATION OF T CELLS: ABATACEPT, file dd9e0c63-240f-1e9c-e053-3a05fe0a45ef
|
2
|
|
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study, file dd9e0c64-9f5d-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c64-c6c6-1e9c-e053-3a05fe0a45ef
|
2
|
|
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome, file dd9e0c64-cdf8-1e9c-e053-3a05fe0a45ef
|
2
|
|
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study, file dd9e0c64-ce6d-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c64-d164-1e9c-e053-3a05fe0a45ef
|
2
|
|
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease, file dd9e0c65-818c-1e9c-e053-3a05fe0a45ef
|
2
|
|
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset, file dd9e0c65-9354-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c65-9758-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c66-06fe-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c66-5324-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c66-56b9-1e9c-e053-3a05fe0a45ef
|
2
|
|
Temporomandibular disorders and oral features in systemic lupus erythematosus patients: An observational study of symptoms and signs, file dd9e0c66-a3ea-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c66-e647-1e9c-e053-3a05fe0a45ef
|
2
|
|
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus, file dd9e0c67-44c8-1e9c-e053-3a05fe0a45ef
|
2
|
|
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients, file dd9e0c67-4ec5-1e9c-e053-3a05fe0a45ef
|
2
|
|
A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies, file dd9e0c69-8295-1e9c-e053-3a05fe0a45ef
|
2
|
|
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA, file dd9e0c69-edd0-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c6a-3b73-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c6b-0d44-1e9c-e053-3a05fe0a45ef
|
2
|
|
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis, file dd9e0c6b-180a-1e9c-e053-3a05fe0a45ef
|
2
|
|
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group, file dd9e0c6b-2b83-1e9c-e053-3a05fe0a45ef
|
2
|
|
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behḉet’s disease using explainable artificial intelligence, file 00167508-380e-4fa5-94ba-c60ab5e59cb7
|
1
|
|
Informed consent and biological agents in rheumatology and internal medicine, file 7468afa9-a8c1-47ea-8d14-68531f312a40
|
1
|
|
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis, file 96aa9aff-c975-4fd3-9fb2-465ee5b64581
|
1
|
|
Development and implementation of the AIDA International Registry for patients with Behçet's disease, file d4673911-f4a4-42cc-8f21-06ac04c1aa75
|
1
|
|
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results, file dd9e0c62-4f6f-1e9c-e053-3a05fe0a45ef
|
1
|
|
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects, file dd9e0c62-753c-1e9c-e053-3a05fe0a45ef
|
1
|
|
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, file dd9e0c62-83a7-1e9c-e053-3a05fe0a45ef
|
1
|
|
Repeated infusions of low-dose infliximab plus methotrexate in psoriathic arthrtritis: immediate benefitis are not maintained after discontinuation of inlfiximab, file dd9e0c63-d0fb-1e9c-e053-3a05fe0a45ef
|
1
|
|
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study, file dd9e0c63-e953-1e9c-e053-3a05fe0a45ef
|
1
|
|
Efficacy of intravenous immunoglobulin therapy in refractory dysphagia in patients with idiophatic inflammatory myipathies, file dd9e0c63-e9a2-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-ebed-1e9c-e053-3a05fe0a45ef
|
1
|
|
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema, file dd9e0c64-a402-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c64-c6c5-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c64-c992-1e9c-e053-3a05fe0a45ef
|
1
|
|
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study, file dd9e0c64-cfd4-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c64-d162-1e9c-e053-3a05fe0a45ef
|
1
|
|
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study, file dd9e0c64-d3f3-1e9c-e053-3a05fe0a45ef
|
1
|
|
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study, file dd9e0c65-4389-1e9c-e053-3a05fe0a45ef
|
1
|
|
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies, file dd9e0c65-4410-1e9c-e053-3a05fe0a45ef
|
1
|
|
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study, file dd9e0c65-44e6-1e9c-e053-3a05fe0a45ef
|
1
|
|
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients, file dd9e0c65-50ef-1e9c-e053-3a05fe0a45ef
|
1
|
| Totale |
2.672 |